“…To keep a sustained GvL, post transplantation, delayed Th2 infusion and allogeneic therapeutic vaccines have a great potential. Similarly in vivo transfer of allogeneic MHC genes [100,69] into tumors can further help in maintaining a threshold GvL. Optimization of this former technique as well as its extension to solid tumors need to be explored.…”